Hemophilia: Molecular diagnosis and alternatives of treatment

The haemophilia is a recessive disease tied to the X chromosome that generally men suffer. The genetic preimplantation diagnosis (GPD), the prenatal diagnosis and the molecular diagnosis of the mutations that cause haemophilia, are realized in isolated investigations (researches) in order to do prim...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2007
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23717
Acceso en línea:
https://repository.urosario.edu.co/handle/10336/23717
Palabra clave:
Blood clotting factor 8
Blood clotting factor 9
Immunosuppressive agent
Parvovirus vector
Clinical trial
Diagnostic value
Drug efficacy
Fluorescence in situ hybridization
Gene mutation
Gene transfer
Genetic screening
Hemophilia
Hemophilia a
Hemophilia b
Heterozygote
Human
Immunoadsorption
Nonhuman
Plasmapheresis
Polymerase chain reaction
Prenatal diagnosis
Primary prevention
Promoter region
Quality of life
Review
Short tandem repeat
Single strand conformation polymorphism
Southern blotting
Stem cell transplantation
Unspecified side effect
Viral gene therapy
X chromosome
Genetics
Hemophilia
Therapy
Rights
License
Abierto (Texto Completo)
id EDOCUR2_d538703259a233bab8b2881b61fb9614
oai_identifier_str oai:repository.urosario.edu.co:10336/23717
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 0e66991c-dd7c-4191-b5e9-0d0933540ab6b3e502fe-cd92-4c25-b132-748b65e5040152094825600193318196002020-05-26T00:04:46Z2020-05-26T00:04:46Z2007The haemophilia is a recessive disease tied to the X chromosome that generally men suffer. The genetic preimplantation diagnosis (GPD), the prenatal diagnosis and the molecular diagnosis of the mutations that cause haemophilia, are realized in isolated investigations (researches) in order to do primary prevention, provide advise to the carriers of the disease and their families, which has allowed to bring to the world children free of this disease and also to improve the quality of life of the affected ones. The hopeful procedures in gene therapy (GT) have shown great effectiveness. The intention is to achieve the normal production of the protein which is absent or it is altered in the affected ones, but at the moment the tests carried out in human beings are stopped. Here are other alternate therapies that although are in phase of investigation, would allow to obtain a production of protein to long term and which have been developed thanks to the understanding of the molecular nature of the coagulation factors. © 2007 Corporación Editora Médica del Valle.application/pdf1657953401208322https://repository.urosario.edu.co/handle/10336/23717engUniversidad del Valle-Facultad de Salud315No. 3308Colombia MedicaVol. 38Colombia Medica, ISSN:16579534, 01208322, Vol.38, No.3 (2007); pp. 308-315https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548670523&partnerID=40&md5=a0e174a80d66c541bd8a2f399674d233Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURBlood clotting factor 8Blood clotting factor 9Immunosuppressive agentParvovirus vectorClinical trialDiagnostic valueDrug efficacyFluorescence in situ hybridizationGene mutationGene transferGenetic screeningHemophiliaHemophilia aHemophilia bHeterozygoteHumanImmunoadsorptionNonhumanPlasmapheresisPolymerase chain reactionPrenatal diagnosisPrimary preventionPromoter regionQuality of lifeReviewShort tandem repeatSingle strand conformation polymorphismSouthern blottingStem cell transplantationUnspecified side effectViral gene therapyX chromosomeGeneticsHemophiliaTherapyHemophilia: Molecular diagnosis and alternatives of treatmentHemofilia: Diagnóstico molecular y alternativas de tratamientoarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Bermeo S.M.Silva C.T.Fonseca Mendoza, Dora JanethRestrepo Fernández, Carlos Martín10336/23717oai:repository.urosario.edu.co:10336/237172022-05-02 07:37:16.645328https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Hemophilia: Molecular diagnosis and alternatives of treatment
dc.title.TranslatedTitle.spa.fl_str_mv Hemofilia: Diagnóstico molecular y alternativas de tratamiento
title Hemophilia: Molecular diagnosis and alternatives of treatment
spellingShingle Hemophilia: Molecular diagnosis and alternatives of treatment
Blood clotting factor 8
Blood clotting factor 9
Immunosuppressive agent
Parvovirus vector
Clinical trial
Diagnostic value
Drug efficacy
Fluorescence in situ hybridization
Gene mutation
Gene transfer
Genetic screening
Hemophilia
Hemophilia a
Hemophilia b
Heterozygote
Human
Immunoadsorption
Nonhuman
Plasmapheresis
Polymerase chain reaction
Prenatal diagnosis
Primary prevention
Promoter region
Quality of life
Review
Short tandem repeat
Single strand conformation polymorphism
Southern blotting
Stem cell transplantation
Unspecified side effect
Viral gene therapy
X chromosome
Genetics
Hemophilia
Therapy
title_short Hemophilia: Molecular diagnosis and alternatives of treatment
title_full Hemophilia: Molecular diagnosis and alternatives of treatment
title_fullStr Hemophilia: Molecular diagnosis and alternatives of treatment
title_full_unstemmed Hemophilia: Molecular diagnosis and alternatives of treatment
title_sort Hemophilia: Molecular diagnosis and alternatives of treatment
dc.subject.keyword.spa.fl_str_mv Blood clotting factor 8
Blood clotting factor 9
Immunosuppressive agent
Parvovirus vector
Clinical trial
Diagnostic value
Drug efficacy
Fluorescence in situ hybridization
Gene mutation
Gene transfer
Genetic screening
Hemophilia
Hemophilia a
Hemophilia b
Heterozygote
Human
Immunoadsorption
Nonhuman
Plasmapheresis
Polymerase chain reaction
Prenatal diagnosis
Primary prevention
Promoter region
Quality of life
Review
Short tandem repeat
Single strand conformation polymorphism
Southern blotting
Stem cell transplantation
Unspecified side effect
Viral gene therapy
X chromosome
Genetics
Hemophilia
Therapy
topic Blood clotting factor 8
Blood clotting factor 9
Immunosuppressive agent
Parvovirus vector
Clinical trial
Diagnostic value
Drug efficacy
Fluorescence in situ hybridization
Gene mutation
Gene transfer
Genetic screening
Hemophilia
Hemophilia a
Hemophilia b
Heterozygote
Human
Immunoadsorption
Nonhuman
Plasmapheresis
Polymerase chain reaction
Prenatal diagnosis
Primary prevention
Promoter region
Quality of life
Review
Short tandem repeat
Single strand conformation polymorphism
Southern blotting
Stem cell transplantation
Unspecified side effect
Viral gene therapy
X chromosome
Genetics
Hemophilia
Therapy
description The haemophilia is a recessive disease tied to the X chromosome that generally men suffer. The genetic preimplantation diagnosis (GPD), the prenatal diagnosis and the molecular diagnosis of the mutations that cause haemophilia, are realized in isolated investigations (researches) in order to do primary prevention, provide advise to the carriers of the disease and their families, which has allowed to bring to the world children free of this disease and also to improve the quality of life of the affected ones. The hopeful procedures in gene therapy (GT) have shown great effectiveness. The intention is to achieve the normal production of the protein which is absent or it is altered in the affected ones, but at the moment the tests carried out in human beings are stopped. Here are other alternate therapies that although are in phase of investigation, would allow to obtain a production of protein to long term and which have been developed thanks to the understanding of the molecular nature of the coagulation factors. © 2007 Corporación Editora Médica del Valle.
publishDate 2007
dc.date.created.spa.fl_str_mv 2007
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:04:46Z
dc.date.available.none.fl_str_mv 2020-05-26T00:04:46Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.issn.none.fl_str_mv 16579534
01208322
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23717
identifier_str_mv 16579534
01208322
url https://repository.urosario.edu.co/handle/10336/23717
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 315
dc.relation.citationIssue.none.fl_str_mv No. 3
dc.relation.citationStartPage.none.fl_str_mv 308
dc.relation.citationTitle.none.fl_str_mv Colombia Medica
dc.relation.citationVolume.none.fl_str_mv Vol. 38
dc.relation.ispartof.spa.fl_str_mv Colombia Medica, ISSN:16579534, 01208322, Vol.38, No.3 (2007); pp. 308-315
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548670523&partnerID=40&md5=a0e174a80d66c541bd8a2f399674d233
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad del Valle-Facultad de Salud
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167739723415552